BRIDGEWATER, NJ / ACCESS Newswire / March 24, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...

DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...

PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Antibodies are secreted immunoglobulin molecules produced mainly by plasma cells. The antigen-binding site of the antibody has a unique structure that allows it to bind antigen in a highly ...

Post the infusion, core liquidity, taking into account banking system liquidity along with government cash balances, will remain in a "comfortable surplus" of 1.6 trillion rupees by March-end from ...

Vyvgart comes as a liquid solution that’s given as an intravenous (IV) infusion. Doctors prescribe Vyvgart for adults with generalized MG who test positive for antibodies against acetylcholine ...

And the drugs do come with risks. Along with the high cost and chance of infusion reactions, the anti-amyloid monoclonal antibody drugs carry boxed warnings for amyloid-related imaging ...

Expert Rev Clin Immunol. 2010;6(4):607-620. Acute infusion reactions can have symptoms including flushing, headache, dizziness, chest discomfort, fevers and stridor. [92] The overwhelming majority ...

What are the risks or complications of using monoclonal antibodies? Infusion reactions are common, and occur during or shortly after monoclonal antibody treatment. These occur when your body has a ...